Adapts to Your Unique Needs.1,2
Now with glucose
levels on Your Smart phone.3
The MiniMed lnsulin 770G
Pump System^
Always Read the Instruction for Use. Medtronic’s (real-time) continuous glucose monitoring (CGM) products are indicated for use by people living with type one diabetes. Guardian™ Sensor 3 may also be used as part of the MiniMed® 770G system^ for people living with Type 1 diabetes age 7 and up.
^Components are sold separately. *Waterproof at time of manufacture up to 3.6 metres for up to 24 hours at a time. See MiniMed® 770G User Guide for a complete description of the waterproof capabilities and proper use instructions.
^Components are sold separately. *Waterproof at time of manufacture up to 3.6 metres for up to 24 hours at a time. See MiniMed® 770G User Guide for a complete description of the waterproof capabilities and proper use instructions.
Request a call-back from a
Diabetes Therapeutic
Consultant today.
Download more information to
take to your healthcare
professional.
Speak with an ambassador to
hear their stories.
.
Request a call today, to discuss the benefits of MiniMed 770G with a Medtronic Diabetes Therapy Consultant.
* By providing information, you understand and agree that your personal information is being collected by Medtronic and entered into a database for the purpose of communicating offers and specials related to Medtronic products, services and technological advancements. We are collecting personal information and are required by law to notify you. Please read our privacy collection statement and privacy policy statement.
PREDICTS
Monitors your glucose levels 24/7 and predicts whether you're going high or low. 1,2
ADAPTS
Continuously adapts to your needs based on your real-time data and personal trends. 1,2
SELF-ADJUSTS
Smooths out highs and lows, with SmartGuardTM tech that increases or decreases lnsulin delivery, every 5 minutes.1,2
MINIMED MOBILE APP
FOR PEOPLE
WITH DIABETES
Your diabetes data can now be viewed on your smartphone, allowing you to easily track your glucose levels and get notified on your phone if you're trending high or low.
Available to download at no cost for most iOS and Android smartphones.
Available to download at no cost for most iOS and Android smartphones.
CARELINK
CONNECT APP
FOR CARE PARTNERS
This app helps keep care partners informed. Securely invite up to 5 people to view pump and sensor data, and receive high and low notifications.
Available to download at no cost for most iOS and Android smartphones.
Available to download at no cost for most iOS and Android smartphones.
FUTURE
SOFTWARE UPDATES
Medtronic continues to work on delivering new technologies to help individuals manage their diabetes. To make these upgrades easily accessible, we are developing technology to update our pump through a software download.*
*New technology described is not currently available for sale in Australia. Any new products are subject to regulatory approval. Offer subject to change without notice.
1 By providing information, you understand and agree that your personal information is being collected by Medtronic and entered into a database for the purpose of communicating offers and specials related to Medtronic products, services and technological advancements. We are collecting personal information and are required by law to notify you. Please read our privacy collection statement and privacy policy statement.
^ Components sold separately. Automated delivery is made possible through combining Medtronic pump and continuous glucose monitoring technology.
1. Bergenstal, R. M. et al. Jama. 2016; 316 (13): 1407 – 1408
2. Garg SK et al. Diabetes Technol Ther. 2017 Mar;19(3):155-163
3. MiniMed 770G IFU
4. Data on File
5. Mueckler JR; Chen J; Alford JG; Gopalakrishnan S; Percentage of patients that the system met or exceeded expectations, for the top 3 attributes queried.
1. Bergenstal, R. M. et al. Jama. 2016; 316 (13): 1407 – 1408
2. Garg SK et al. Diabetes Technol Ther. 2017 Mar;19(3):155-163
3. MiniMed 770G IFU
4. Data on File
5. Mueckler JR; Chen J; Alford JG; Gopalakrishnan S; Percentage of patients that the system met or exceeded expectations, for the top 3 attributes queried.